Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1)

Christian Morath, MD, Anita Schmitt, MD, Christian Kleist, PhD, Volker Daniel, MD, Gerhard Opelz, MD, Caner Süsal, MD, Florian Kälble, MD, Claudia Sommerer, MD, Lei Wang, MD, Angela Hückelhoven, PhD, Arianeb Mehrabi, MD, Uta Merle, MD, Luiza Pego da Silva, Carsten Müller-Tidow, MD, Martin Zeier, MD, Matthias Schaier, MD, Michael Schmitt, MD PhD, Peter Terness, MD

Blood (2018) 132 (Supplement 1): 4539.

https://doi.org/10.1182/blood-2018-99-113386

Published: 2018

Journal Articles

Improved Outcome of Haploidentical Peripheral Blood Stem Cell Transplant Treating Severe Aplastic Anemia

Stephen Yang Liang, MD

Blood (2017) 130 (Supplement 1): 3227.

https://doi.org/10.1182/blood.V130.Suppl_1.3227.3227

Published: 2017

Journal Articles

Mycophenolate Mofetil (MMF)-Induced Colitis

Prajwal Dhakal, MBBS, Rakesh Gami, MBBS, Smith Giri, MBBS, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 4795.

https://doi.org/10.1182/blood.V128.22.4795.4795

Published: 2016

Journal Articles

Everolimus and Mycophenolate as GvHD Prophylaxis Results In Improved Control of Advanced Disease and Reduced Bacterial and Fungal Infectious Complications After Allogeneic Stem Cell Transplantation

Reinhard E Marks, Hartmut Bertz, Ralph M. Waesch, MD, Wolfgang Melchinger, Juergen Finke

Blood (2010) 116 (21): 1264.

https://doi.org/10.1182/blood.V116.21.1264.1264

Published: 2010

Journal Articles

GvHD Prophylaxis with Everolimus and Mycophenolate in Allogeneic Hematopoietic Cell Transplantation - A Phase I/II Study.

Reinhard Marks, Alf Zerweck, Razvan George Racila, Hartmut Bertz, Jürgen Finke

Blood (2009) 114 (22): 4642.

https://doi.org/10.1182/blood.V114.22.4642.4642

Published: 2009

Journal Articles

Analysis of a New graft–versus-host Disease (GvHD) Prophylaxis Regimen with Additional Enteric-coated Mycophenolate Sodium (EC-MPS) Starting 10 Days after Unrelated Allogeneic Stem Cell Transplantation.

Herbert G. Sayer, Lars-Olof Mügge, Sebastian Scholl, Anne Klink, Kristina Schilling, Klaus Höffken

Blood (2008) 112 (11): 2202.

https://doi.org/10.1182/blood.V112.11.2202.2202

Published: 2008

NARROW

Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1)

Improved Outcome of Haploidentical Peripheral Blood Stem Cell Transplant Treating Severe Aplastic Anemia

Mycophenolate Mofetil (MMF)-Induced Colitis

Everolimus and Mycophenolate as GvHD Prophylaxis Results In Improved Control of Advanced Disease and Reduced Bacterial and Fungal Infectious Complications After Allogeneic Stem Cell Transplantation

GvHD Prophylaxis with Everolimus and Mycophenolate in Allogeneic Hematopoietic Cell Transplantation - A Phase I/II Study.

Analysis of a New graft–versus-host Disease (GvHD) Prophylaxis Regimen with Additional Enteric-coated Mycophenolate Sodium (EC-MPS) Starting 10 Days after Unrelated Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1)

Improved Outcome of Haploidentical Peripheral Blood Stem Cell Transplant Treating Severe Aplastic Anemia

Mycophenolate Mofetil (MMF)-Induced Colitis

Everolimus and Mycophenolate as GvHD Prophylaxis Results In Improved Control of Advanced Disease and Reduced Bacterial and Fungal Infectious Complications After Allogeneic Stem Cell Transplantation

GvHD Prophylaxis with Everolimus and Mycophenolate in Allogeneic Hematopoietic Cell Transplantation - A Phase I/II Study.

Analysis of a New graft–versus-host Disease (GvHD) Prophylaxis Regimen with Additional Enteric-coated Mycophenolate Sodium (EC-MPS) Starting 10 Days after Unrelated Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only